On the afternoon of September 3, 2025, Yiteng Pharmaceuticals, Shanghai Pudong Development Bank Hong Kong Branch, Shanghai Pudong Development Bank Suzhou Branch, and SPDB International signed a four-party strategic cooperation agreement at the Suzhou Branch.

Yiteng Pharmaceuticals is a full industry chain pharmaceutical enterprise with innovative drug clinical research and development capabilities, high-end production and manufacturing systems, and a comprehensive commercial operation network. The company focuses on therapeutic areas with significant unmet clinical needs, including anti-infection, respiratory system, and cardiovascular diseases, and has established a series of high-quality commercialized product portfolios. Through more than twenty years of development, the company has successfully promoted multiple innovative drugs to market in China, demonstrating exceptional clinical development and management capabilities.

This four-party strategic cooperation centers on "investment-banking linkage" as its core theme, aiming to integrate the comprehensive financial service resources of Shanghai Pudong Development Bank and SPDB International in the financial and investment sectors to provide comprehensive, multi-level, and cross-cycle financial support for Yiteng Pharmaceuticals. The three financial institutions will jointly build a financial ecosystem covering all development stages of Yiteng Pharmaceuticals through a collaborative model of "commercial banking services + investment banking services," helping accelerate its innovative drug research and development and global market expansion.

Yiteng Pharmaceuticals Chairman Ni Xin, Shanghai Pudong Development Bank Hong Kong Branch General Manager and SPDB International Executive Director Jia Hongrui, Shanghai Pudong Development Bank Suzhou Branch Party Secretary and General Manager Hua Wei, and SPDB International Corporate Finance Department Co-General Manager Chen Si respectively signed the agreement on behalf of each party.

This signing ceremony not only marks a new starting point for the four-party cooperation but also signifies the deepening advancement of strategic collaboration among all parties. In the future, Shanghai Pudong Development Bank Hong Kong Branch, Suzhou Branch, and SPDB International will coordinate and collaborate to provide integrated ecological financial services for Yiteng Pharmaceuticals, continuously deepening comprehensive cooperation in multiple areas including funding, capital, and resources. Together, they will build a long-term stable strategic partnership, safeguard the interests of all parties, promote win-win development, and gradually establish the "Yiteng Pharmaceuticals-Shanghai Pudong Development Bank-SPDB International" strategic alliance.